Literature DB >> 2937470

Human endothelial cells synthesize protein S.

D S Fair, R A Marlar, E G Levin.   

Abstract

Human umbilical vein endothelial cells were analyzed for the presence of prothrombin, factor VII, protein C, and protein S in culture supernatants and cell extracts using specific radioimmunoassays. Only protein S was detected. Conditioned medium from 24-hour cultures and cell lysates contained 21.7 ng/mL and 88.8 ng/10(7) cells of protein S, respectively. Intrinsic labeling and immunoprecipitation indicated that protein S was synthesized and secreted as a 75,000 molecular weight protein. Vitamin K, phorbol myristate acetate, and thrombin increased the production or specific activity (determined from activity/antigen ratios of 0.99 to 1.07, 0.93 to 1.04, and 0.90 to 1.04, respectively) of protein S. While untreated cells secreted a partially active protein S (activity/antigen = 0.40), warfarin greatly decreased the specific activity (less than 0.10) of this molecule, suggesting that endothelial cells contain the enzymes required for the carboxylation of selected glutamic acid residues. The production of protein S by these cells supports the hypothesis that cofactor production and expression by the endothelial cells may play a significant regulatory role in the initiation, propagation, and suppression of hemostasis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937470

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.

Authors:  Bridget Shafit-Zagardo; Ross C Gruber; Juwen C DuBois
Journal:  Pharmacol Ther       Date:  2018-03-04       Impact factor: 12.310

Review 2.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

3.  Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.

Authors:  Adil Anwar; Amy K Keating; David Joung; Susan Sather; Grace K Kim; Kelly K Sawczyn; Luis Brandão; Peter M Henson; Douglas K Graham
Journal:  J Leukoc Biol       Date:  2009-04-22       Impact factor: 4.962

4.  Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

Authors:  Donghui Zhu; Yaoming Wang; Itender Singh; Robert D Bell; Rashid Deane; Zhihui Zhong; Abhay Sagare; Ethan A Winkler; Berislav V Zlokovic
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

Review 5.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

6.  Identification of vitamin K-dependent carboxylase activity in lung type II cells but not in lung macrophages.

Authors:  R Wallin; S R Rannels
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

Review 7.  Induced Pluripotent Stem Cell-Derived Endothelial Cells: Overview, Current Advances, Applications, and Future Directions.

Authors:  Sae Jang; Alexandra Collin de l'Hortet; Alejandro Soto-Gutierrez
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

8.  Interaction of vitamin-K-dependent coagulation factors and the endothelium.

Authors:  P P Nawroth; D M Stern
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

9.  Direct measurement of vitamin K-dependent enzymes in various isolated and cultured tumor and non-tumor cells.

Authors:  M A de Boer-van den Berg; M P Uitendaal; C Vermeer
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

10.  LPS-Toll-Like Receptor-Mediated Signaling on Expression of Protein S and C4b-Binding Protein in the Liver.

Authors:  Tatsuya Hayashi; Koji Suzuki
Journal:  Gastroenterol Res Pract       Date:  2010-08-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.